Siver Andreas Moestue1, Vickie Yi Zhang2,
Else Marie Huuse1, Beathe Sitter1, Gunhild Mari
Mlandsmo3, Olav Engebrten3, Ingrid Susann Gribbestad1
1Department of Circulation and Medical
Imaging, Norwegian University of Science and Technology, Trondheim, Norway; 2Department
of Radiology and Biomedical Imaging, UCSF, San Francisco, United States; 3Department
of Tumor Biology, Institute for Cancer Research, Oslo, Norway
An
estrogen-dependent luminal-like breast cancer xenograft model was used to
study choline metabolites after endocrine therapy using HR MAS MRS. The data
suggested that choline metabolite concentrations do not change following
endocrine therapy wheras taurine and lactate do change.